OTC · Financial Statements

Entia Biosciences, Inc. (ERGO) Financial Statements

$0.00 OTC: ERGO Market Cap $6732

Entia Biosciences, Inc. most recently reported annual revenue of $0, a net loss of $1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20122013201420152016
Revenue$0$0$1.0M$0$0
Operating Profit$-1.0M$-3.0M$-2.0M$-2.0M$-1.0M
Net Profit$-2.0M$-3.0M$-3.0M$-2.0M$-1.0M
EPS$-0.21$-0.43$-0.28$-0.10$-0.05
Op Margin-292.6%-852.0%-269.8%-552.3%-439.8%

Balance Sheet (USD)

Metric20122013201420152016
Total Assets$0$1.0M$1.0M$0$0
Total Liabilities$1.0M$2.0M$1.0M$1.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$1.0M

Cash Flow (USD)

Metric20122013201420152016
Operating Cash Flow$0$-1.0M$-1.0M$-1.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$1.0M$0$1.0M$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$-1.0M$-1.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.75
FCF Yield-10728.09%
Quick Ratio0.08
Interest Coverage-13.98
Return 1Y0.00%
Return 3Y0.00%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
ERGO Overview ERGO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.